- This event has passed.
What do you know about the legal cases fighting for the right to access therapeutic use of psilocybin?
June 19 @ 12:00 pm - 1:30 pm
$10- Psychedelics Legality and Ethics in Colorado: Where We Are vs. Where We Want to Be - December 20, 2024
- Lessons from the Massachusetts Ballot Campaign: What Happened and What’s Next? - December 13, 2024
- The Fight to Advance Psilocybin Therapy for Life-Threatening Conditions - November 22, 2024
Join our discussion on the groundbreaking efforts to establish federal safe harbor for psilocybin-assisted therapy for individuals with life-threatening conditions. We’ll explore the current legal status of psilocybin as a Schedule I substance, the challenges this poses for access to therapy, and potential pathways for change, including the Right to Try Act and rescheduling efforts. We’ll also delve into the significant litigation, AIMS et al v. DEA, and its impact on inspiring federal bills like the Right to Try Clarification Act and the Breakthrough Therapies Act. This is a critical conversation about expanding treatment options and improving access to innovative therapies. This community forum will be led by Kathryn L. Tucker, a national leader in improving care for seriously ill patients, with advocacy roles at organizations like the National Psychedelics Association and Compassion & Choices. Britt Rollins, who is a co-founder of the National Psychedelics Association and a seasoned communications strategist in healthcare, will be the interviewer in this forum.
Wednesday, June 9th, 2021 from 12-1:30pm PST
REGISTER FOR THIS EVENT HERE
There is growing enthusiasm in Jewish communities about possible ancient use and modern applications of plant medicine in Jewish spiritual development. Psychedelic Judaism introduce new potential modes of healing...